» Articles » PMID: 30709026

Guggulsterone Activates Adipocyte Beiging Through Direct Effects on 3T3-L1 Adipocytes and Indirect Effects Mediated Through RAW264.7 Macrophages

Overview
Specialty Pharmacology
Date 2019 Feb 3
PMID 30709026
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Plant-derived phytochemicals have been of emerging interest as anti-obesity compounds due to their apparent effects on promoting reduced lipid accumulation in adipocytes. Despite such promising evidence, little is known about the potential mechanisms behind their anti-obesity effects. The aim of this study is to establish potential anti-obesity effects of the phytochemical guggulsterone (GS). Mature 3T3-L1 adipocytes were treated with GS, derived from the guggul plant native in northern India, to investigate its effects on mitochondrial biogenesis and adipocyte "beiging." Further, to explore the relationship between macrophages and adipocytes, 3T3-L1s were treated with conditioned media from GS-treated RAW264.7 macrophages. Markers of mitochondrial biogenesis and beiging were measured by western blot. GS treatment in adipocytes resulted in increased mitochondrial density, biogenesis (PGC1α and PPARγ), and increased markers of a beige adipocyte phenotype (UCP1, TBX1, and β-3AR). This upregulation in mitochondrial expression was accompanied by increases oxygen consumption. In GS-treated macrophages, markers of M2 polarization were elevated (e.g., arginase and IL-10), along with increased catecholamine release into the media. Lastly, 3T3-L1 adipocytes treated with conditioned media from macrophages induced a 167.8% increase in UCP1 expression, suggestive of a role of macrophages in eliciting an anti-adipogenic response to GS. Results from this study provide the first mechanistic understanding of the anti-obesity effects of GS and suggests a role for both direct GS-signaling and indirect stimulation of M2 macrophage polarization in this model.

Citing Articles

Sitosterol-rich against 7-ketocholesterol and lipopolysaccharide-mediated atherogenic responses by modulating NF-ΚB/iNOS signalling pathway in macrophages.

Ravi S, Duraisamy P, Krishnan M, Martin L, Manikandan B, Ramar M 3 Biotech. 2023; 13(10):331.

PMID: 37670802 PMC: 10475456. DOI: 10.1007/s13205-023-03741-6.


Antiaging Mechanism of Natural Compounds: Effects on Autophagy and Oxidative Stress.

Taylor E, Kim Y, Zhang K, Chau L, Nguyen B, Rayalam S Molecules. 2022; 27(14).

PMID: 35889266 PMC: 9322024. DOI: 10.3390/molecules27144396.


Endocrine disrupting chemicals: Friend or foe to brown and beige adipose tissue?.

Francis C, Allee L, Nguyen H, Grindstaff R, Miller C, Rayalam S Toxicology. 2021; 463:152972.

PMID: 34606950 PMC: 9165749. DOI: 10.1016/j.tox.2021.152972.


Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect.

Preethi L, Ganamurali N, Dhanasekaran D, Sabarathinam S Obes Med. 2021; 24:100346.

PMID: 33942025 PMC: 8081575. DOI: 10.1016/j.obmed.2021.100346.


Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products.

Jakab J, Miskic B, Miksic S, Juranic B, Cosic V, Schwarz D Diabetes Metab Syndr Obes. 2021; 14:67-83.

PMID: 33447066 PMC: 7802907. DOI: 10.2147/DMSO.S281186.


References
1.
Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante Jr A . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12):1796-808. PMC: 296995. DOI: 10.1172/JCI19246. View

2.
Shishodia S, Aggarwal B . Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J Biol Chem. 2004; 279(45):47148-58. DOI: 10.1074/jbc.M408093200. View

3.
Shi T, Wang F, Stieren E, Tong Q . SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem. 2005; 280(14):13560-7. DOI: 10.1074/jbc.M414670200. View

4.
Ichikawa H, Aggarwal B . Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin Cancer Res. 2006; 12(2):662-8. DOI: 10.1158/1078-0432.CCR-05-1749. View

5.
Deng R . Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Cardiovasc Drug Rev. 2007; 25(4):375-90. DOI: 10.1111/j.1527-3466.2007.00023.x. View